Yong-Feng Su
Overview
Explore the profile of Yong-Feng Su including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang Y, Wang A, Su Y, Wang J, Li Y, Li F, et al.
Front Immunol
. 2024 Sep;
15:1409302.
PMID: 39221255
Introduction: The prognosis of relapsed/refractory acute myeloid leukemia (r/rAML) is dismal, and allogeneic hematopoietic stem cell transplant (allo-HSCT) is a potential cure. Combining anti-PD-1, hypomethylating agent (HMA), and CAG (cytarabine,...
2.
Gao X, Su Y, Li M, Jing Y, Wang J, Xu L, et al.
Cancer Immunol Immunother
. 2023 May;
72(8):2769-2782.
PMID: 37166484
Anti-PD-1 monotherapy had limited clinical efficacy in relapsed/refractory (r/r) AML patients with higher PD-1 and PD-L1 expression. Hence, we investigated the efficacy and safety of PD-1 inhibitor with DNA hypomethylating...
3.
Zhang H, Gu J, Chao A, Cheng Q, Teng D, Yu J, et al.
Acta Pharmacol Sin
. 2022 Jul;
44(2):446-453.
PMID: 35896694
The current study evaluated the efficacy and safety of a denosumab biosimilar, QL1206 (60 mg), compared to placebo in postmenopausal Chinese women with osteoporosis and high fracture risk. At 31...
4.
Su Y, Wang Y, Ning H, Hu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2021 Dec;
29(6):1945-1949.
PMID: 34893139
Objective: To analyze the factors influencing the mobilization of autologous peripheral blood stem cells (auto-PBSCs) in patients with lymphoma and multiple myeloma, and provide reference for optimizing the autologous stem...
5.
Ning H, Wang J, Su Y, Xu C, Hu J, Lou X, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2019 Dec;
27(6):1736-1741.
PMID: 31839031
Objective: To explore the role of bone marrow niche in the chemotherapy resistance of patient with acute myeloid leukemia (AML), and to investigate the effects of the MSCs on the...
6.
Ning H, Wang J, Su Y, Xu C, Hu J, Lou X, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2019 Aug;
27(4):1277-1286.
PMID: 31418393
Objective: To study the influence of acute myeloid leukemia (AML) microenvironment on mesenchymal stem cells (MSCs). Methods: MSCs were isolated from the bone marrow of newly diagnosed AML patients (AML-MSCs)...
7.
Ning H, Wang J, Su Y, Xu C, Hu J, Lou X, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2019 Aug;
27(4):1259-1264.
PMID: 31418390
Objective: To explore the role of bone marrow microenvironment(niche) in the development of acute myeloid leukemia (AML) and the effect of AML patients-derived MSC on the proliferation, cell cycle and...
8.
Wan L, Chen J, Xu C, Li B, Hu J, Lou X, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2017 Apr;
25(2):530-534.
PMID: 28446306
Objective: To investigate the relationship between NK cell count/activity and acute graft-versus-host disease (aGVHD) in patients receiving allogeneic hematopoietic stem cell transplantation (allo-HSCT). Methods: A total of 26 patients who...
9.
Liu N, Ning H, Hu L, Jiang M, Xu C, Hu J, et al.
Leuk Res
. 2015 Nov;
39(12):1375-81.
PMID: 26530539
To further find effective method to improve the long term survival of refractory or relapsed acute myeloid leukemia (AML) patients, we retrospectively analyzed the outcomes of myeloablative hematopoietic stem cell...
10.
Shi R, Xu M, Su Y, Zhang B, Chen H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
. 2012 Aug;
28(8):793-6.
PMID: 22863581
Aim: To detect the gene expression of signal molecules involved in the Notch pathway after co-culture of umbilical cord mesenchymal stem cells (UC-MSCs) and CD34(+); hematopoietic stem cells. Methods: UC-MSCs...